Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 73.60% | -1,205.71% | 37.20% | 88.60% | -1,539.72% |
| Total Depreciation and Amortization | 3.47% | -3.49% | 5.77% | 5.96% | -0.89% |
| Total Amortization of Deferred Charges | -12.73% | 1.34% | 0.54% | -0.40% | 0.68% |
| Total Other Non-Cash Items | -93.08% | 1,123.38% | 3,206.22% | -100.25% | 5,591.96% |
| Change in Net Operating Assets | -272.68% | 158.65% | 121.07% | -547.29% | -72.25% |
| Cash from Operations | -211.43% | -24.65% | 305.91% | -208.69% | -45.01% |
| Capital Expenditure | 31.92% | 10.07% | -68.63% | 66.28% | -6.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 349.46% | -110.92% | 137.23% | -63.53% | 1,169.06% |
| Cash from Investing | 44.96% | -44.92% | -45.66% | 67.11% | 16.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15,064.01% | -0.80% | -0.20% | -0.20% | -1.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3,068.42% | 32.14% | 98.05% | -308.26% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -357.54% | 33.11% | -25.82% | 2.37% | 18.82% |
| Cash from Financing | -29,295.18% | 254.82% | 140.71% | -219.15% | -39.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,229.52% | -56.57% | 186.50% | -185.83% | -713.13% |